Abstract
The physiological basis for the use of non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of acute pelvic pain in women was examined in terms of: (i) the electrophysiological responses of epithelial cells in the human Fallopian tube; and (ii) the longitudinal and circular contractions of the myosalpinx. Epithelial cells were grown as a polarized layer in primary culture, and transepithelial potential difference (p.d.) and short-circuit current (Iscc) were recorded using a modified Ussing chamber. The inflammatory mediators histamine (0.1–100.0 µmol l-1) and platelet activating factor (PAF) (1.9–1900.0 nmol l-1) increased p.d. and Iscc in a dose-dependent manner. Pre-incubation with the NSAID diclofenac sodium (100 µmol l-1) inhibited the histamine- and PAF-induced stimulation of p.d. and Iscc. Aspirin (100 µmol l-1), ibuprofen (100 µmol l-1), indomethacin (100 µmol l-1) or naproxen (100 µmol l-1) were only partially effective. Histamine (0.1–1000.0 µmol l-1) increased the frequency of contractions of longitudinal and circular smooth muscle in segments of Fallopian tube in vitro, in a dose-dependent manner. Pre-incubation with diclofenac significantly reduced the histamine-induced stimulation of tubal smooth muscle contraction at the higher doses of histamine. The other NSAIDs had no effect. These data provide evidence that diclofenac downregulates acute inflammation in the human Fallopian tube and may be of use as an anti-inflammatory agent in the treatment of pelvic inflammatory disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.